Biodexa Pharmaceuticals (BDRX) Debt Ratio (2013 - 2025)

Biodexa Pharmaceuticals (BDRX) has 13 years of Debt Ratio data on file, last reported at 0.69 in Q4 2025.

• For the quarter ending Q4 2025, Debt Ratio rose 7.93% year-over-year to 0.69; the trailing twelve-month figure through Dec 2025 stood at 0.69 (up 7.93% YoY), and the FY2025 full-year result was 0.69, up 7.93% from the prior year.
• Debt Ratio advanced to 0.69 in Q4 2025, from 0.03 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.92 in Q4 2021 to a low of 0.01 in Q2 2024.
• A 5-year average of 0.57 and a median of 0.69 in 2025 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio sank 94.68% in 2023 and soared 126.96% in 2025, its largest moves.
• Tracing BDRX's Debt Ratio over 5 years: stood at 0.92 in 2021, then retreated by 4.82% to 0.88 in 2022, then retreated by 22.19% to 0.68 in 2023, then dropped by 6.68% to 0.64 in 2024, then grew by 7.93% to 0.69 in 2025.
• Business Quant data shows BDRX's Debt Ratio at 0.69 in Q4 2025, 0.03 in Q2 2025, and 0.64 in Q4 2024.